May 5, 2020 / 10:21 PM / 19 days ago

BRIEF-Acorda Reports First Quarter 2020 Financial Results And Provides Business Update

May 5 (Reuters) - Acorda Therapeutics Inc:

* ACORDA REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 NON-GAAP LOSS PER SHARE $0.51

* Q1 GAAP LOSS PER SHARE $0.14

* REITERATES 2020 AMPYRA NET REVENUE GUIDANCE AND OPERATING EXPENSE GUIDANCE

* WITHDRAWS 2020 INBRIJA NET REVENUE GUIDANCE DUE TO ONGOING COVID-19 PANDEMIC

* ACORDA THERAPEUTICS - AT MARCH 31, HAD CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS,RESTRICTED CASH OF $126.3 MILLION VERSUS $168.9 MILLION AT YEAR END 2019

* FOR FULL-YEAR 2020, ACORDA CONTINUES TO EXPECT AMPYRA NET REVENUE TO BE $85 - $110 MILLION

* CONTINUES TO EXPECT INBRIJA PEAK SALES IN 2020 TO BE $300 MILLION - $500 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below